“This is not a time that we should be pulling back,” says Catherine Wu. “It’s a very, very exciting time in the field.”
File photo by Stephanie Mitchell/Harvard Staff Photographer
Alvin Powell
Harvard Staff Photographer
August 31, 2026
6 min read
Groundbreaking treatments and vaccines offer hope in fight against cancer
The Moderna cancer vaccine offers hope — now we must speed up personalized therapies
After a rough stretch, mRNA gets a boost — at least for now
What’s in Merck and Moderna’s cancer vaccine algorithm?
There have been several promising developments lately in cancer research and treatment, including a new drug approved by the FDA…
Merck and Moderna’s personalized mRNA cancer vaccine helps prevent melanoma recurrence and spread, raising hopes for use against…
Between success with a pancreatic cancer drug and now success with an mRNA neoantigen vaccine, it has been a banner year for…
Merck and Moderna’s success with a personalized cancer vaccine designed to keep melanoma at bay opens a new avenue of treatment…
News of first positive large late-stage trial result for drug could signal new era for treating solid-tumor cancers, with tests…
Editorial: A drug for pancreatic cancer shows immense promise, but we shouldn’t forget research in the field is a story of small…
